134 related articles for article (PubMed ID: 38630822)
21. Spatial Positioning and Matrix Programs of Cancer-Associated Fibroblasts Promote T-cell Exclusion in Human Lung Tumors.
Grout JA; Sirven P; Leader AM; Maskey S; Hector E; Puisieux I; Steffan F; Cheng E; Tung N; Maurin M; Vaineau R; Karpf L; Plaud M; Begue AL; Ganesh K; Mesple J; Casanova-Acebes M; Tabachnikova A; Keerthivasan S; Lansky A; Berichel JL; Walker L; Rahman AH; Gnjatic S; Girard N; Lefevre M; Damotte D; Adam J; Martin JC; Wolf A; Flores RM; Beasley MB; Pradhan R; Muller S; Marron TU; Turley SJ; Merad M; Kenigsberg E; Salmon H
Cancer Discov; 2022 Nov; 12(11):2606-2625. PubMed ID: 36027053
[TBL] [Abstract][Full Text] [Related]
22. Role of podoplanin, E-cadherin, Ki-67 in the dissemination of tumor cells in ovarian surface epithelial carcinoma-An immunohistochemical study.
Varghese JR; Gurusamy DS; Kalyanasundaram S; Kalyanaraman S
Ann Diagn Pathol; 2022 Oct; 60():151984. PubMed ID: 35785646
[TBL] [Abstract][Full Text] [Related]
23. Role of tertiary lymphoid organs in the regulation of immune responses in the periphery.
Bery AI; Shepherd HM; Li W; Krupnick AS; Gelman AE; Kreisel D
Cell Mol Life Sci; 2022 Jun; 79(7):359. PubMed ID: 35689679
[TBL] [Abstract][Full Text] [Related]
24. Single-Cell RNA Sequencing Reveals the Tissue Architecture in Human High-Grade Serous Ovarian Cancer.
Xu J; Fang Y; Chen K; Li S; Tang S; Ren Y; Cen Y; Fei W; Zhang B; Shen Y; Lu W
Clin Cancer Res; 2022 Aug; 28(16):3590-3602. PubMed ID: 35675036
[TBL] [Abstract][Full Text] [Related]
25. Identity thieves: T cells steal CD20 from B cells but mark themselves for certain death.
Sumida TS; O'Connor KC
Sci Immunol; 2022 May; 7(71):eabq7242. PubMed ID: 35522724
[TBL] [Abstract][Full Text] [Related]
26. Spatially mapping the immune landscape of melanoma using imaging mass cytometry.
Moldoveanu D; Ramsay L; Lajoie M; Anderson-Trocme L; Lingrand M; Berry D; Perus LJM; Wei Y; Moraes C; Alkallas R; Rajkumar S; Zuo D; Dankner M; Xu EH; Bertos NR; Najafabadi HS; Gravel S; Costantino S; Richer MJ; Lund AW; Del Rincon SV; Spatz A; Miller WH; Jamal R; Lapointe R; Mes-Masson AM; Turcotte S; Petrecca K; Dumitra S; Meguerditchian AN; Richardson K; Tremblay F; Wang B; Chergui M; Guiot MC; Watters K; Stagg J; Quail DF; Mihalcioiu C; Meterissian S; Watson IR
Sci Immunol; 2022 Apr; 7(70):eabi5072. PubMed ID: 35363543
[TBL] [Abstract][Full Text] [Related]
27. Spatially resolved transcriptomics of high-grade serous ovarian carcinoma.
Stur E; Corvigno S; Xu M; Chen K; Tan Y; Lee S; Liu J; Ricco E; Kraushaar D; Castro P; Zhang J; Sood AK
iScience; 2022 Mar; 25(3):103923. PubMed ID: 35252817
[TBL] [Abstract][Full Text] [Related]
28. Longitudinal single-cell RNA-seq analysis reveals stress-promoted chemoresistance in metastatic ovarian cancer.
Zhang K; Erkan EP; Jamalzadeh S; Dai J; Andersson N; Kaipio K; Lamminen T; Mansuri N; Huhtinen K; Carpén O; Hietanen S; Oikkonen J; Hynninen J; Virtanen A; Häkkinen A; Hautaniemi S; Vähärautio A
Sci Adv; 2022 Feb; 8(8):eabm1831. PubMed ID: 35196078
[TBL] [Abstract][Full Text] [Related]
29. Single-cell tumor-immune microenvironment of BRCA1/2 mutated high-grade serous ovarian cancer.
Launonen IM; Lyytikäinen N; Casado J; Anttila EA; Szabó A; Haltia UM; Jacobson CA; Lin JR; Maliga Z; Howitt BE; Strickland KC; Santagata S; Elias K; D'Andrea AD; Konstantinopoulos PA; Sorger PK; Färkkilä A
Nat Commun; 2022 Feb; 13(1):835. PubMed ID: 35149709
[TBL] [Abstract][Full Text] [Related]
30. Single-cell RNA-seq recognized the initiator of epithelial ovarian cancer recurrence.
Kan T; Zhang S; Zhou S; Zhang Y; Zhao Y; Gao Y; Zhang T; Gao F; Wang X; Zhao L; Yang M
Oncogene; 2022 Feb; 41(6):895-906. PubMed ID: 34992217
[TBL] [Abstract][Full Text] [Related]
31. Clinicopathologic predictors of early relapse in advanced epithelial ovarian cancer: development of prediction models using nationwide data.
Said SA; Bretveld RW; Koffijberg H; Sonke GS; Kruitwagen RFPM; de Hullu JA; van Altena AM; Siesling S; van der Aa MA
Cancer Epidemiol; 2021 Dec; 75():102008. PubMed ID: 34509380
[TBL] [Abstract][Full Text] [Related]
32. Single-cell transcriptomes reveal heterogeneity of high-grade serous ovarian carcinoma.
Hao Q; Li J; Zhang Q; Xu F; Xie B; Lu H; Wu X; Zhou X
Clin Transl Med; 2021 Aug; 11(8):e500. PubMed ID: 34459128
[TBL] [Abstract][Full Text] [Related]
33. Spatially organized multicellular immune hubs in human colorectal cancer.
Pelka K; Hofree M; Chen JH; Sarkizova S; Pirl JD; Jorgji V; Bejnood A; Dionne D; Ge WH; Xu KH; Chao SX; Zollinger DR; Lieb DJ; Reeves JW; Fuhrman CA; Hoang ML; Delorey T; Nguyen LT; Waldman J; Klapholz M; Wakiro I; Cohen O; Albers J; Smillie CS; Cuoco MS; Wu J; Su MJ; Yeung J; Vijaykumar B; Magnuson AM; Asinovski N; Moll T; Goder-Reiser MN; Applebaum AS; Brais LK; DelloStritto LK; Denning SL; Phillips ST; Hill EK; Meehan JK; Frederick DT; Sharova T; Kanodia A; Todres EZ; Jané-Valbuena J; Biton M; Izar B; Lambden CD; Clancy TE; Bleday R; Melnitchouk N; Irani J; Kunitake H; Berger DL; Srivastava A; Hornick JL; Ogino S; Rotem A; Vigneau S; Johnson BE; Corcoran RB; Sharpe AH; Kuchroo VK; Ng K; Giannakis M; Nieman LT; Boland GM; Aguirre AJ; Anderson AC; Rozenblatt-Rosen O; Regev A; Hacohen N
Cell; 2021 Sep; 184(18):4734-4752.e20. PubMed ID: 34450029
[TBL] [Abstract][Full Text] [Related]
34. High-grade serous tubo-ovarian cancer refined with single-cell RNA sequencing: specific cell subtypes influence survival and determine molecular subtype classification.
Olbrecht S; Busschaert P; Qian J; Vanderstichele A; Loverix L; Van Gorp T; Van Nieuwenhuysen E; Han S; Van den Broeck A; Coosemans A; Van Rompuy AS; Lambrechts D; Vergote I
Genome Med; 2021 Jul; 13(1):111. PubMed ID: 34238352
[TBL] [Abstract][Full Text] [Related]
35. Co-evolution of matrisome and adaptive adhesion dynamics drives ovarian cancer chemoresistance.
Pietilä EA; Gonzalez-Molina J; Moyano-Galceran L; Jamalzadeh S; Zhang K; Lehtinen L; Turunen SP; Martins TA; Gultekin O; Lamminen T; Kaipio K; Joneborg U; Hynninen J; Hietanen S; Grénman S; Lehtonen R; Hautaniemi S; Carpén O; Carlson JW; Lehti K
Nat Commun; 2021 Jun; 12(1):3904. PubMed ID: 34162871
[TBL] [Abstract][Full Text] [Related]
36. Characterizing the tumor microenvironment of metastatic ovarian cancer by single-cell transcriptomics.
Olalekan S; Xie B; Back R; Eckart H; Basu A
Cell Rep; 2021 May; 35(8):109165. PubMed ID: 34038734
[TBL] [Abstract][Full Text] [Related]
37. Single-cell Profiles and Prognostic Impact of Tumor-Infiltrating Lymphocytes Coexpressing CD39, CD103, and PD-1 in Ovarian Cancer.
Laumont CM; Wouters MCA; Smazynski J; Gierc NS; Chavez EA; Chong LC; Thornton S; Milne K; Webb JR; Steidl C; Nelson BH
Clin Cancer Res; 2021 Jul; 27(14):4089-4100. PubMed ID: 33963000
[TBL] [Abstract][Full Text] [Related]
38. Single-cell dissection of cellular components and interactions shaping the tumor immune phenotypes in ovarian cancer.
Hornburg M; Desbois M; Lu S; Guan Y; Lo AA; Kaufman S; Elrod A; Lotstein A; DesRochers TM; Munoz-Rodriguez JL; Wang X; Giltnane J; Mayba O; Turley SJ; Bourgon R; Daemen A; Wang Y
Cancer Cell; 2021 Jul; 39(7):928-944.e6. PubMed ID: 33961783
[TBL] [Abstract][Full Text] [Related]
39. SIO: A Spatioimageomics Pipeline to Identify Prognostic Biomarkers Associated with the Ovarian Tumor Microenvironment.
Zhu Y; Ferri-Borgogno S; Sheng J; Yeung TL; Burks JK; Cappello P; Jazaeri AA; Kim JH; Han GH; Birrer MJ; Mok SC; Wong STC
Cancers (Basel); 2021 Apr; 13(8):. PubMed ID: 33917869
[TBL] [Abstract][Full Text] [Related]
40. Plasma cells shape the mesenchymal identity of ovarian cancers through transfer of exosome-derived microRNAs.
Yang Z; Wang W; Zhao L; Wang X; Gimple RC; Xu L; Wang Y; Rich JN; Zhou S
Sci Adv; 2021 Feb; 7(9):. PubMed ID: 33627414
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
